Identification of proteins differentially expressed between capillary endothelial cells of hepatocellular carcinoma and normal liver in an orthotopic rat tumor model using 2-D DIGE

Proteomics

Volumn 10, Issue 2, 2010, Pages 224-234

  Jia, Jinghui ^a   Wang, Jingyu ^a   Teh, Ming ^b   Sun, Wei ^a   Zhang, Jianhua ^a   Kee, Irene ^c   Chow, Pierce K H ^c   Liang, Rosa Cynthia M Y ^a   Chung, Maxey C M ^a,b   Ge, Ruowen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

2 D DIGE; Animal proteomics; Hepatocellular carcinoma; Sinusoid endothelial cell; Tumor endothelial cell

Indexed keywords

CELL MARKER; EH DOMAIN CONTAINING PROTEIN 3; GALECTIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CELL ISOLATION; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER SINUSOID; LIVER TRANSPLANTATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; RAT; TUMOR GROWTH; TUMOR MODEL; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL SEPARATION; CELL SHAPE; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, DISC; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOTHELIAL CELLS; GALECTIN 3; HUMANS; LIVER; LIVER NEOPLASMS; MALE; PROTEOME; RATS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; RATTUS;

EID: 76749123529     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900607     Document Type: Article

References (37)

1. Lin, T. Y., Lee, C. S., Chen, K. M., Chen, C. C., Role of surgery in the treatment of primary carcinoma of the liver: a 31-year experience. Br. J. Surg. 1987, 74, 839-842.
2. Carmeliet, P., Angiogenesis in health and disease. Nat. Med. 2003, 9, 653-660.
3. Kerbel, R., Folkman, J., Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2002, 2, 727-739.
4. Graepler, F., Verbeek, B., Graeter, T., Smirnow, I. et al., Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC. Hepatology 2005, 41, 879-886.
5. Kin, M., Torimura, T., Ueno, T., Nakamura, T. et al., Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats. Int. J. Oncol. 2000, 16, 375-382.
6. Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y. et al., Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development. J. Hepatol. 2004, 41, 97-103.
7. Yoshiji, H., Kuriyama, S., Hicklin, D. J., Huber, J. et al., KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells. Hepatology 1999, 30, 1179-1186.
8. Frachon, S., Gouysse, G., Dumortier, J., Couvelard, A. et al., Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. J. Hepatol. 2001, 34, 850-857.
9. Gervaz, P., Scholl, B., Mainguene, C., Poitry, S., et al., Angiogenesis of liver metastases: role of sinusoidal endothelial cells. Dis. Colon Rectum 2000, 43, 980-986.
10. Kimura, H., Nakajima, T., Kagawa, K., Deguchi, T. et al., Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver 1998, 18, 14-19.
11. Yang, Z. F., Ho, D. W., Lam, C. T., Luk, J. M. et al., Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma. Cancer Res. 2005, 65, 219-225.
12. Tokairin, T., Nishikawa, Y., Doi, Y., Watanabe, H. et al., A highly specific isolation of rat sinusoidal endothelial cells by the immunomagnetic bead method using SE-1 monoclonal antibody. J. Hepatol. 2002, 36, 725-733.
13. Braet, F., De Zanger, R., Sasaoki, T., Baekeland, M. et al., Assessment of a method of isolation, purification, and cultivation of rat liver sinusoidal endothelial cells. Lab. Invest. 1994, 70, 944-952.
14. Lee, Y. H., Boelsterli, U. A., Lin, Q., Chung, M. C. M., Proteomics profiling of hepatic mitochondria in heterozygous Sod2+/- mice, an animal model of discreet mitochondrial oxidative stress. Proteomics 2008, 8, 555-568.
15. Mortz, E., Krogh, T. N., Vorum, H., Görg, A., Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 2001, 1, 1359-1363.
16. Neo, J. C. H., Rose, P., Ong, C. N., Chung, M. C. M., beta-Phenylethyl isothiocyanate mediated apoptosis: a proteomic investigation of early apoptotic protein changes. Proteomics 2005, 5, 1075-1082.
17. Ohmura, T., Enomoto, K., Satoh, H., Sawada, N., Mori, M., Establishment of a novel monoclonal antibody, SE-1, which specifically reacts with rat hepatic sinusoidal endothelial cells. J. Histochem. Cytochem. 1993, 41, 1253-1257.
18. Couvelard, A., Scoazec, J. Y., Feldmann, G., Expression of cell-cell and cell-matrix adhesion proteins by sinusoidal endothelial cells in the normal and cirrhotic human liver. Am. J. Pathol. 1993, 143, 738-752.
19. McGuire, R. F., Bissell, D. M., Boyles, J., Roll, F. J., Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver. Hepatology 1992, 15, 989-997.
20. Kin, M., Torimura, T., Ueno, T., Inuzuka, S., Tanikawa, K., Sinusoidal capillarization in small hepatocellular carcinoma. Pathol. Int. 1994, 44, 771-778.
21. Nakamura, S., Muro, H., Suzuki, S., Sakaguchi, T. et al., Immunohistochemical studies on endothelial cell phenotype in hepatocellular carcinoma. Hepatology 1997, 26, 407-415.
22. Sakamoto, M., Ino, Y., Fujii, T., Hirohashi, S., Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma. Jpn. J. Clin. Oncol. 1993, 23, 98-104.
23. Chen, J., Yu, L., Li, D., Gao, Q. et al., Human CRYL1, a novel enzyme-crystallin overexpressed in liver and kidney and downregulated in 58% of liver cancer tissues from 60 Chinese patients, and four new homologs from other mammalians. Gene 2003, 302, 103-113.
24. Ryschich, E., Lizdenis, P., Ittrich, C., Benner, A. et al., Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma. Cancer Res. 2006, 66, 198-211.
25. Naslavsky, N., McKenzie, J., Altan-Bonnet, N., Sheff, D., Caplan, S., EHD3 regulates early-endosome-to-Golgi transport and preserves Golgi morphology. J. Cell Sci. 2009, 122, 389-400.
26. Liu, F. T., Rabinovich, G. A., Galectins as modulators of tumour progression. Nat. Rev. Cancer 2005, 5, 29-41.
27. Hsu, D. K., Dowling, C. A., Jeng, K. C., Chen, J. T. et al., Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int. J. Cancer 1999, 81, 519-526.
28. Matsuda, Y., Yamagiwa, Y., Fukushima, K., Ueno, Y., Shimosegawa, T., Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma. Hepatol. Res. 2008, 38, 1098-1111.
29. St Croix, B., Rago, C., Velculescu, V., Traverso, G. et al., Genes expressed in human tumor endothelium. Science 2000, 289, 1197-1202.
30. Seaman, S., Stevens, J., Yang, M. Y., Logsdon, D. et al., Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 2007, 11, 539-554.
31. Xiong, Y. Q., Sun, H. C., Zhang, W., Zhu, X. D. et al., Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Clin. Cancer Res. 2009, 15, 4838-4846.
32. Folkman, J., Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1, 27-31.
33. Haratake, J., Hisaoka, M., Yamamoto, O., Horie, A., An ultrastructural comparison of sinusoids in hepatocellular carcinoma, adenomatous hyperplasia, and fetal liver. Arch. Pathol. Lab. Med. 1992, 116, 67-70.
34. Yu, D., Sun, X., Qiu, Y., Zhou, J. et al., Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma. Clin. Cancer Res. 2007, 13, 3814-3824.
35. Thijssen, V. L., Hulsmans, S., Griffioen, A. W., The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. Am. J. Pathol. 2008, 172, 545-553.
36. Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S. et al., Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am. J. Pathol. 2000, 156, 899-909.
37. Thijssen, V. L. J. L., Postel, R., Brandwijk, R. J. M. G. E., Dings, R. P. M. et al., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc. Natl. Acad. Sci. USA 2006, 103, 15975-15980.